According to recent studies and RCTs in various countries, the antiparasitic drug ivermectin – a WHO essential medicine – is achieving a covid-19 risk reduction of up to 98% in pre-exposure prophylaxis and up to 91% in early treatment. A recent French study found a reduction in severe and fatal covid by 100% even in... Continue Reading →
Source